Request for Covid-19 Impact Assessment of this Report
Market Dynamics
The factors that drive growth for the Injectables Drug-delivery devices Market include increasing cases of chronic diseases like cancer. The health issues that may arise from the use of needles is a major challenge for this industry. Another challenge for this industry is the regulatory uncertainties.
The market also throws up several opportunities with regard to a large number of technological developments.
Market Segmentation
The market is segmented in terms of the type, mode of delivery, therapeutic use, and geography.
In terms of the product type, the market is classified into self-injection type and conventional injection type.
In terms of mode of delivery, the market is segmented into nasal, oral, ocular, injectable, transdermal and topical.
The different geographic market segments are North America, Europe, Asia Pacific and Rest of the world.
Regional/Geographic Analysis
North America is the dominating market in terms of market share due to the greater awareness and high incomes. North America is followed by Europe in terms of market share. But in terms of growth rate, Asia Pacific is the expected to be the leader because of the increasing awareness amongst the public and the developing infrastructure
Key Players
Some of the major players in the market include Polymer Factory, Alkermes Inc., Pearl Therapeutics Inc, QLT Inc, UCB Group, Bend Research, BIND Biosciences, Inc.
The report contains comprehensive analysis on:
Global Injectables Drug-delivery devices Market Segments
Global Injectables Drug-delivery devices Market Drivers, Restraints and Opportunities
Global Injectables Drug-delivery devices Market Size & Forecast 2016 to 2022
Supply & Demand Value Chain
Global Injectables Drug-delivery devices Market Current Trends
Competition & Major Companies
Technology and R&D Status
Porters Five Force Analysis
Strategic and Critical Success Factor Analysis of Key Players
Regional analysis for Global Injectables Drug-delivery devices Market includes
--> North America
>> US and Canada
--> Latin America
>> Mexico, Brazil, Argentina and Rest of Latin America
--> Western Europe
>> EU5 (Germany, France, Italy, Spain, U.K.)
>> Nordic Countries (Denmark, Finland, Norway, and Sweden)
>> Benelux (Belgium, The Netherlands, and Luxembourg)
>> Rest of Western Europe
--> Eastern Europe
>> Russia
>> Poland
>> Rest of Eastern Europe
--> Asia Pacific
>> China
>> India
>> Japan
>> Australia and New Zealand
>> Rest of Asia Pacific
--> Middle East and Africa
>> GCC countries (Saudi Arabia, Oman, Qatar, Bahrain, UAE and Kuwait)
>> South Africa
>> North Africa
>> Rest of Middle East and Africa
This report is an elaborate aggregation of primary inputs from industry experts and participants across the supply chain. It provides in-depth market segmentation that is derived from extensive product mapping exercises, macro-economic factors and other qualitative and quantitative insights. The impact of all such factors are delivered across multiple market segments and geographies.
Report Highlights::
--> Detailed Historical Overview (Market Origins, Product Launch Timeline, etc.)
--> Consumer and Pricing Analysis
--> Market dynamics of the industry
--> In-depth Market Segmentation
--> Historical and Projected Market Sizing in terms of volume and value
--> Recent market trends and Impact Factors
--> R&D Status and Technology Overview
--> Extensive Industry Structure Coverage
Proteins that are designed and engineered in the laboratory for pharmaceutical interventions to treat different diseases are known as protein therapeutics. The global protein therapeutics market accounted for $140,109 million in 2016, and is anticipated to rea...
Umbilical cord blood bank is storage facility that collects cord blood after the childbirth from placenta. Cord blood is rich source of stem cell used in treatment of different chronic diseases. Private and public cord blood banks are the two major types of banks that are prevalent in th...
The pharmaceutical agents that are administered to treat, diagnose, and prevent life-threatening diseases (rare diseases) are known as orphan drugs. The global orphan drugs market accounted for $106 billion in 2015, and is anticipated to reach $169 billio...